Anthony Tang, ACC 2021: Findings from the RAFT-AF Trial

It was a great pleasure to meet with Anthony Tang to discuss the RAFT-AF trial results investigating the safety and efficacy of catheter ablation-based rhythm control compared with rate control for the treatment of patients with atrial fibrillation and heart failure, presented at ACC 2021.

Abstract Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus rate control Trial in patients with heart failure and high burden Atrial Fibrillation – RAFT-AF

Questions:

1. What were the aims and design of the RAFT study? (0:19)
2. What were the key inclusion criteria of the study? (0:44)
3. Could you tell us a little about the study findings in terms of primary and secondary outcomes, and the reasons for early termination of the study? (1:44)
4. How did these findings compare with other studies comparing rhythm-control and rate-control strategies among patients with atrial fibrillation and heart failure? (5:58)
5. What are the implications of these findings for the management of patients with atrial fibrillation and heart failure, and what future studies are needed? (7:50)

Speaker disclosures: Anthony Tang has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed during a remote video call with Professor Anthony Tang as a highlight of ACC 2021, May 2021.